72 related articles for article (PubMed ID: 7693480)
1. Multiple signaling pathways mediate anti-Ig and IL-4-induced early response gene expression in human tonsillar B cells.
Murphy JJ; Norton JD
Eur J Immunol; 1993 Nov; 23(11):2876-81. PubMed ID: 7693480
[TBL] [Abstract][Full Text] [Related]
2. A mutant of the WEHI-231 B lymphocyte line that is resistant to phorbol esters is still sensitive to antigen receptor-mediated growth inhibition.
Haggerty HG; Monroe JG
Cell Immunol; 1994 Mar; 154(1):166-80. PubMed ID: 8118885
[TBL] [Abstract][Full Text] [Related]
3. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
Klemsz MJ; Justement LB; Palmer E; Cambier JC
J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
[TBL] [Abstract][Full Text] [Related]
4. Activation of dense human tonsilar B cells. Induction of c-myc gene expression via two distinct signal transduction pathways.
White MW; McConnell F; Shu GL; Morris DR; Clark EA
J Immunol; 1991 Feb; 146(3):846-53. PubMed ID: 1703181
[TBL] [Abstract][Full Text] [Related]
5. IL-4 promotes anti-Ig-mediated protein kinase C translocation and reverses phorbol ester-mediated protein kinase C down-regulation in murine B cells.
Harnett MM; Holman MJ; Klaus GG
J Immunol; 1991 Dec; 147(11):3831-6. PubMed ID: 1940370
[TBL] [Abstract][Full Text] [Related]
6. Requirements of a costimulus for IL-4-induced IgE class switching in murine B cells activated via antigen receptors: effectiveness of 8-mercaptoguanosine.
Hikida M; Takai T; Ohmori H
J Immunol; 1996 Apr; 156(8):2730-6. PubMed ID: 8609390
[TBL] [Abstract][Full Text] [Related]
7. Activation of a novel serine/threonine kinase that phosphorylates c-Fos upon stimulation of T and B lymphocytes via antigen and cytokine receptors.
Nel AE; Taylor LK; Kumar GP; Gupta S; Wang SC; Williams K; Liao O; Swanson K; Landreth GE
J Immunol; 1994 May; 152(9):4347-57. PubMed ID: 8157958
[TBL] [Abstract][Full Text] [Related]
8. CD20 monoclonal antibodies down-regulate IgM at the surface of B cells.
Bourget I; Breittmayer JP; Grenier-Brossette N; Cousin JL
Eur J Immunol; 1993 Mar; 23(3):768-71. PubMed ID: 7680616
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line.
Dornand J; Bouaboula M; d'Angeac AD; Favero J; Shire D; Casellas P
J Cell Physiol; 1992 Apr; 151(1):71-80. PubMed ID: 1560050
[TBL] [Abstract][Full Text] [Related]
10. B cell early response gene expression coupled to B cell receptor, CD40 and interleukin-4 receptor co-stimulation: evidence for a role of the egr-2/krox 20 transcription factor in B cell proliferation.
Newton JS; Li J; Ning ZQ; Schoendorf DE; Norton JD; Murphy JJ
Eur J Immunol; 1996 Apr; 26(4):811-6. PubMed ID: 8625972
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of c-fos expression is a component of the mIg signal transduction mechanism but is not indicative of competence for proliferation.
Monroe JG
J Immunol; 1988 Mar; 140(5):1454-60. PubMed ID: 3126226
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4 signals regulating CD23 gene expression in human B cells: protein kinase C-independent signaling pathways.
Lee CE; Yoon SR; Pyun KH
Cell Immunol; 1993 Jan; 146(1):171-85. PubMed ID: 8425225
[TBL] [Abstract][Full Text] [Related]
13. Antigen-induced Fc receptor-dependent and -independent B cell desensitization. An elevation in [Ca2+]i is not sufficient and protein kinase C activation is not required for these pathways of surface IgM-mediated desensitization.
Lazarus AH; Mills GB; Crow AR; Delovitch TL
J Immunol; 1991 Sep; 147(6):1739-45. PubMed ID: 1890301
[TBL] [Abstract][Full Text] [Related]
14. Anti-IgM and anti-IgG modulate c-fos RNA levels differently in human B lymphocytes.
Shu J; Benedict SH; Chan MA
Cell Immunol; 1994 Dec; 159(2):170-83. PubMed ID: 7994752
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of c-fos inhibits down-regulation of a cyclin-dependent kinase-2 inhibitor p27Kip1 in splenic B cells activated by surface Ig cross-linking.
Kobayashi K; Phuchareon J; Inada K; Tomita Y; Koizumi T; Hatano M; Miyatake S; Tokuhisa T
J Immunol; 1997 Mar; 158(5):2050-6. PubMed ID: 9036948
[TBL] [Abstract][Full Text] [Related]
16. Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals.
Clark EA; Shu GL; Lüscher B; Draves KE; Banchereau J; Ledbetter JA; Valentine MA
J Immunol; 1989 Dec; 143(12):3873-80. PubMed ID: 2480376
[TBL] [Abstract][Full Text] [Related]
17. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
18. Egr-1 expression in surface Ig-mediated B cell activation. Kinetics and association with protein kinase C activation.
Seyfert VL; McMahon S; Glenn W; Cao XM; Sukhatme VP; Monroe JG
J Immunol; 1990 Dec; 145(11):3647-53. PubMed ID: 2246508
[TBL] [Abstract][Full Text] [Related]
19. Selective induction of high levels of IgA synthesis in Peyer's patch B cells by protein kinase C-activating phorbol esters.
Li YS; Dearden-Badet MT; Revillard JP
J Immunol; 1991 Sep; 147(6):1752-8. PubMed ID: 1909730
[TBL] [Abstract][Full Text] [Related]
20. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway.
Carey GB; Semenova E; Qi X; Keegan AD
Cell Res; 2007 Nov; 17(11):942-55. PubMed ID: 17968425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
